Skip to main content
. 2015 Jul 1;17(6):1395–1406. doi: 10.1208/s12248-015-9797-6

Fig. 6.

Fig. 6

Simulation of mean plasma concentration-time profiles of galunisertib after oral administration of 150 mg in solution to healthy human subjects in Trial 1. Time is truncated in the inset to better show the fitting of the earlier time points